Shares of Cerner Co. (NASDAQ:CERN) have received a consensus recommendation of “Buy” from the sixteen research firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $73.36.
Several analysts have recently commented on CERN shares. Citigroup increased their price objective on Cerner from $77.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Cantor Fitzgerald increased their price objective on Cerner from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, July 8th. Wells Fargo & Co increased their price objective on Cerner from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 25th. Barclays reissued a “hold” rating and issued a $68.00 price objective on shares of Cerner in a research note on Wednesday, April 10th. Finally, Canaccord Genuity increased their price objective on Cerner from $77.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th.
In other news, CAO Michael R. Battaglioli sold 10,468 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $69.09, for a total value of $723,234.12. Following the completion of the transaction, the chief accounting officer now directly owns 8,226 shares of the company’s stock, valued at $568,334.34. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William D. Zollars sold 1,400 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $72.11, for a total value of $100,954.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 441,468 shares of company stock valued at $30,777,997. Company insiders own 0.75% of the company’s stock.
CERN stock traded down $0.96 during trading on Friday, reaching $70.97. 2,207,367 shares of the stock were exchanged, compared to its average volume of 2,038,243. The business’s 50 day simple moving average is $73.27. Cerner has a twelve month low of $48.78 and a twelve month high of $76.47. The company has a current ratio of 2.52, a quick ratio of 2.50 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $22.81 billion, a price-to-earnings ratio of 32.11, a P/E/G ratio of 2.05 and a beta of 0.92.
Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.02. Cerner had a return on equity of 15.14% and a net margin of 10.75%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the prior year, the business earned $0.62 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. As a group, sell-side analysts predict that Cerner will post 2.43 EPS for the current year.
The business also recently disclosed a special dividend, which was paid on Friday, July 26th. Stockholders of record on Tuesday, June 18th were paid a $0.18 dividend. The ex-dividend date was Monday, June 17th. Cerner’s dividend payout ratio (DPR) is presently 32.58%.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Recommended Story: Options Trading – Understanding Strike Price
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.